Literature DB >> 11519163

[Rheumatic disease and depression].

S Kawakatsu1, T Wada.   

Abstract

We reviewed depressive symptoms in rheumatic disease. In systemic lupus erythematosus(SLE), depressive symptoms are frequently mentioned with the prevalence rate about 30% and usually respond to antidepressant. The duration of symptoms is within two months in most patients. Antibodies to ribosomal P protein appear to be a specific marker for SLE with depression. Single photon emission tomography but magnetic resonance imaging may also be useful for predicting the development of depressive symptoms. We also reported a patient of dermatomyositis with manic-depressive state who showed decreased cerebral blood flow in the left frontal and temporal regions during depressive state.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11519163

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  3 in total

1.  Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience.

Authors:  Zahra Zakeri; Mansoor Shakiba; Behzad Narouie; Nikol Mladkova; Mohammad Ghasemi-Rad; Alireza Khosravi
Journal:  Rheumatol Int       Date:  2011-01-21       Impact factor: 2.631

Review 2.  Late consequences of chronic pediatric illness.

Authors:  Susan Turkel; Maryland Pao
Journal:  Psychiatr Clin North Am       Date:  2007-12

3.  Depression in Patients with Systemic Lupus Erythematosus: A Multicenter Study.

Authors:  Ibrahim Abdulrazag Al-Homood; Narges E Omran; Abdulrahman S Alwahibi; Maha Aldosoghy; Amal Alharthy; Ghassan S Aljohani
Journal:  Saudi J Med Med Sci       Date:  2017-08-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.